FundedIQ
Biotechnology

Helaina: Funding, Investors & Team (Sep 2026)

Helaina is a biotechnology firm that creates baby formula similar to breast milk as an alternative. The company uses fermentation to produce bioactive proteins that provide immune benefits and nutrition similar to breast milk, creating a new range of functional food products. By replicating functional proteins found in the human body, Helaina offers these nutrients as innovative options.

www.myhelaina.com LinkedIn New York, United States 51-100 employees
Biotechnology Health Care Parenting Personal Health B2B
Total raised
$65.0M
Rounds
2
Latest
Series B
Sep 2024

Helaina has raised $65.0M across 2 funding rounds on record, the most recent a Series B of $45.0M announced in Sep 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Helaina Company Profile and Key Stats

Total funding raised
$65.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$45.0M in Sep 2024
Employees
51-100
reported band
Headquarters
New York, United States

Latest funding round on record: Sep 2024.

Helaina Funding Rounds

Date
Round
Amount
Series B
$45.0M
Series A
$20.0M

Helaina raised $20.0M in a Series A announced in Nov 2021.

2.8 years later, a Series B of $45.0M was announced in Sep 2024.

Helaina Founders and Leadership Team

Name
Role
Contact
Laura Katz
Founder
Locked

Contact details for the Helaina team: 1 of 1 has an email address on file.

Start 14-day free trial →

Helaina Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
4,307
$30M

Helaina's latest round of $45.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Helaina in Biotechnology and New York

Companies Similar to Helaina

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Helaina Funding FAQs

What does Helaina do?

Helaina is a biotechnology firm that creates baby formula similar to breast milk as an alternative. The company uses fermentation to produce bioactive proteins that provide immune benefits and nutrition similar to breast milk, creating a new range of functional food products. By replicating functional proteins found in the human body, Helaina offers these nutrients as innovative options.

How much funding has Helaina raised?

Helaina has raised $65.0M across 2 rounds on record. The most recent is a Series B of $45.0M announced in Sep 2024.

When did Helaina last raise funding?

Helaina's most recent funding round on record is a Series B of $45.0M, announced in Sep 2024.

Who founded Helaina?

FundedIQ lists Laura Katz (Founder) at Helaina.

Where is Helaina headquartered?

Helaina is based in New York, United States.

How many employees does Helaina have?

Helaina is in the 51-100 employee band.

How does Helaina's funding compare to other Biotechnology startups?

Helaina's latest round of $45.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Helaina Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Helaina is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.